SCHEMBL4607947

SCHEMBL4607947

CC(C)(C)[Si](C)(C)OCC#CCc1ccccc1N

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3940682 0.78 BACE1 (0.44) BACE1
SCHEMBL1474688 0.75 DUT (0.35) BACE1
SCHEMBL29823262 0.75 DUT (0.35) BACE1
SCHEMBL8664580 0.73 HRH3 (0.35)
SCHEMBL2168948 0.73
SCHEMBL8069572 0.73 DUT (0.39) BACE1
SCHEMBL6702684 0.73 BACE1 (0.41) BACE1
SCHEMBL8526099 0.70 CYP1A2 (0.41)
SCHEMBL8922566 0.70 CHRNB2 (0.38)
SCHEMBL5196496 0.70 AGXT (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945206-A1 INDOLE DERIVATIVES AS HISTAMINE 3 RECEPTOR INHIBITORS FOR THE TREATMENT OF COGNITIVE AND SLEEP DISORDERS, OBESITY AND OTHER CNS DISORDERS Athersys, Inc. (US) 2008-07-23 EP disclosed
WO-2007047775-A1 INDOLE DERIVATIVES AS HISTAMINE 3 RECEPTOR INHIBITORS FOR THE TREATMENT OF COGNITIVE AND SLEEP DISORDERS, OBESITY AND OTHER CNS DISORDERS ATHERSYS, INC. (US) 2007-04-26 WO disclosed